{"id":"paper-cju-2026-082958","type":"book","url":"https://diginpl.com/books/paper-cju-2026-082958","language":"en","name":"Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations","name_en":"Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations","name_ne":null,"description":"Canadian Journal of Urology · Jeanny B. Aragon-Ching, Ravi A. Madan · 2026","headline":"Canadian Journal of Urology · Jeanny B. Aragon-Ching, Ravi A. Madan · 2026","also_known_as":[],"summary":"","summary_more":[],"facts":[{"key":"authors","label":"Author","values":[{"text":"Jeanny B. Aragon-Ching"},{"text":"Ravi A. Madan"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/cju.2026.082958"}},{"key":"published","label":"Published","values":[{"text":"2026","date":"2026"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/cju.2026.082958"}},{"key":"publisher","label":"Publisher","values":[{"text":"Tech Science Press"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/cju.2026.082958"}},{"key":"journal","label":"Journal","values":[{"text":"Canadian Journal of Urology"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/cju.2026.082958"}},{"key":"doi","label":"DOI","values":[{"text":"10.32604/cju.2026.082958","url":"https://doi.org/10.32604/cju.2026.082958"}],"source":{"label":"Crossref","url":"https://doi.org/10.32604/cju.2026.082958"}}],"office":null,"sections":[],"cited":[],"cited_from":null,"videos":[],"last_reviewed":null,"organizations":[],"same_as":["https://doi.org/10.32604/cju.2026.082958"],"faq":[{"q":"Who wrote Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations?","a":"Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations was written by Jeanny B. Aragon-Ching, Ravi A. Madan."},{"q":"When was Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations first published?","a":"Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations was first published in 2026."}],"related":[],"places_in":[],"nearby":[],"image":null,"sources":[{"label":"Publisher record (DOI, via Crossref)","url":"https://doi.org/10.32604/cju.2026.082958","license":null}],"license":null,"attribution":"Open-access publication. Read it free at the publisher: https://doi.org/10.32604/cju.2026.082958.","cite":"\"Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations\". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-cju-2026-082958. Retrieved 14 November 2026.","date_modified":"2026-10-02T00:04:53Z","facts_checked":"2026-11-02","alternates":{"html":"https://diginpl.com/books/paper-cju-2026-082958","en":"https://diginpl.com/books/paper-cju-2026-082958","ne":null}}